In cancer, angiogenesis is hijacked to supply the growing tumor with nutrients and oxygen. Tumors secrete high levels of VEGF and other growth factors to stimulate blood vessel growth. Targeting angiogenesis has become a therapeutic strategy in cancer treatment, with drugs such as Bevacizumab (a VEGF inhibitor) being used to starve tumors of their blood supply.
